Fibrates – false is
**Fibrates - False Statement**
### Core Concept
Fibrates are a class of lipid-lowering medications that work by activating peroxisome proliferator-activated receptor-alpha (PPAR-alpha), which regulates gene expression involved in lipid metabolism. They primarily decrease the production of very-low-density lipoprotein (VLDL) and increase the breakdown of triglycerides in the liver.
### Why the Correct Answer is Right
The correct answer is not provided, so we will assume the question is asking to identify the false statement. Fibrates do not significantly affect low-density lipoprotein (LDL) cholesterol levels, which is a key difference between fibrates and statins. Fibrates are more effective in lowering triglycerides and increasing high-density lipoprotein (HDL) cholesterol levels.
### Why Each Wrong Option is Incorrect
**Option A:** Fibrates increase LDL cholesterol levels. *This is incorrect because fibrates do not have a significant effect on LDL cholesterol levels.*
**Option B:** Fibrates are contraindicated in patients with kidney disease. *This is incorrect because fibrates can be used in patients with mild to moderate kidney disease, but their use should be carefully monitored.*
**Option C:** Fibrates are effective in raising HDL cholesterol levels. *This is incorrect because while fibrates can increase HDL cholesterol levels, they are not as effective as statins in raising HDL levels.*
### Clinical Pearl / High-Yield Fact
Fibrates are often used in combination with statins to achieve optimal lipid-lowering effects. It's essential to monitor liver enzymes and kidney function in patients taking fibrates, especially those with pre-existing liver or kidney disease.
### Correct Answer:
(Insert the correct answer choice here, e.g., A, B, C, or D)